a magnifying glass

adobe pdf icon Analogic Corporation Signs Agreement with Sphere Medical to Develop Innovative Glucose Monitor for Critical Care Market

Analogic Corporation Signs Agreement with Sphere Medical to Develop Innovative Glucose Monitor for Critical Care Market

Analogic Corporation Signs Agreement with Sphere Medical to Develop Innovative Glucose Monitor for Critical Care Market

PEABODY, Mass.–(BUSINESS WIRE)–July 24, 2006–Analogic
Corporation (NASDAQ: ALOG) today announced that the Company has
entered into an agreement with Sphere Medical of Cambridge, UK, to
develop and manufacture instruments for the monitoring of key blood
parameters, such as glucose, blood gases, and electrolytes, in
critical care patients.

Hyperglycemia, or high blood-sugar levels, is a common condition
in critically ill patients that can significantly increase the
possibility of death. Close control of glucose in these patients,
according to the landmark Van den Bergh study, can result in improved
patient outcomes and reduced patient mortality.

Stuart Hendry, Sphere Medical’s CEO, said, “Our proprietary
Proxima system will initially be applied to the monitoring of glucose,
in which there is a strong current interest. However, critical care
patients need frequent testing of many blood parameters, and our
capability of simultaneously measuring other key blood components,
such as blood gases and electrolytes, sets us apart in the field. Our
focus at Sphere is on the continual improvement of critical care. By
teaming with Analogic, a recognized leader in signal processing and
the development of advanced medical instrumentation, we will bring a
new generation of products to the critical care arena, which will give
clinicians better control over the therapy delivered with expected
improvements in patient outcomes.”

“Analogic has a history of developing world-class patient monitors
for leading Original Equipment Manufacturers (OEMs),” said Dan
Webster, General Manager, Analogic Life Care Systems Division. “We
look forward to working with Sphere Medical to raise the standard of
patient monitoring in critical care that will both improve and save
lives.”

Analogic Corporation is a leading designer and manufacturer of
advanced health and security systems and subsystems sold primarily to
Original Equipment Manufacturers (OEMs). The Company is recognized
worldwide for advancing the state of the art in Computed Tomography
(CT), Digital Radiography (DR), Ultrasound, Magnetic Resonance Imaging
(MRI), and Patient Monitoring.

Sphere Medical Limited is developing highly innovative monitoring
products to provide clinical and economic benefits in the critical
care environment, based on the company’s proprietary technology. The
products allow minimally invasive, real time measurement of clinical
chemistry parameters and therapeutic drug concentrations, giving
healthcare professionals the information they require to more
effectively manage therapy and optimise patient outcomes. Sphere
Medical is a private company, founded in 2002 and based in Cambridge,
UK. For further information please see www.spheremedical.com.

    CONTACT: Analogic Corporation
             Paul M. Roberts, 978-326-4213
             proberts@analogic.com

    SOURCE: Analogic Corporation